🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Details
- Coupon Rate
- 11.00%
- Liquidation Preference
- $17.50
- Call Price
- $17.50
- Call / Redemption Date
- —
- Maturity Date
- None
- Distribution Period
- M
- Rate Type
- Fixed
- Annual Distribution
- 1.925
- Distribution Dates
- 15th day of the Month
- Credit Ratings
- Moody's NF · S&P NF (10/8/2021)
- Tax-Advantaged Dividends
- Yes
Security Profile
- Market Cap
- Small Cap
- IPO
- 3/2/2020 · $17.50/share
- Parent Company
- Aytu BioScience, Inc. (AYTU)
Business: Aytu BioScience, Inc., 11% Series I Cumulative Redeemable Preferred Stock, liquidation preference $17.50 share, redeemable at the issuer's option on or after (__)/2025 at $17.50 per share plus accrued and unpaid dividends, and with no stated maturity. <p> Cumulative distributions of 11% per annum ($1.925 per annum or $0.16041666 per month) will be paid Monthly on the 15th day of each month to holders of record on the record date that will be the last day of the month preceding the payment date (NOTE: the ex-dividend date is one business day prior to the record date). <p> Dividends paid by this preferred security are eligible for the preferential income tax rate of 15% to a maximum of 20% depending on the holder's tax bracket (and under IRS specified holding restrictions) and are also eligible for the dividends received deduction for corporate holders (see page S-26 of the prospectus for further information). <p> Upon the occurrence of a change of control resulting in the common shares of the surviving entity no longer being listed on the NYSE, the AMEX or the Nasdaq exchanges the company will have the option within 120 days to redeem the preferred shares at $17.50 per share plus accrued and unpaid dividends. <p> This security was not rated by Moody’s or S&P at the time of its IPO. In regard to the payment of dividends and upon liquidation, the preferred shares rank junior to the company's senior debt, equally with other preferreds of the company, and senior to the common shares of the company. See the IPO prospectus for further information on the preferred stock by clicking on the ‘Link to IPO Prospectus’ provided below.
Notes: Quantum Online found no evidence that this security was ever listed on an exchange after being issued.
Company Contact
- CEO
- Josh Disbrow
- CFO
- Ryan J. Selhorn
- Headquarters
- 7900 East Union Avenue, Suite 920, Denver, CO 80237
- Phone
- 720-437-6580 · Toll-Free 855-298-8246
- Investor Relations
- 720-437-6580 · investors@aytubio.com